Meningococcal vaccines account for the largest vaccine segment in the global travel vaccines market and is expected to generate revenue of around $900 million by 2020, says Technavio. Technavio has announced its latest market research report on travel vaccines for the forecast period, 2016-2020. This market analysis, under the vaccines vertical, discusses the major drivers and…
Pneumococcal vaccine: Key market research findings The Americas dominate the market geographically PCV accounts for a majority share of the market’s revenue Key vendors – Pfizer, Sanofi, GSK, and Merck Technavio’s market research analysts predict the global pneumococcal vaccine market to grow at a CAGR of more than 8% between 2016 and 2020. The…
Meningococcal vaccine: Key market research findings The Americas to dominate the market geographically Increasing preference for combination vaccines in the market Key vendors – GSK, Pfizer, and Sanofi Technavio’s market research analysts predict the global meningococcal vaccine market to grow at a CAGR of around 13% between 2016 and 2020. The market’s growth is…
H1N1 vaccines: Key market research findings Global plan for influenza vaccines drives market growth Intramuscular vaccines segment is the dominant shareholder in the market Key vendors – Sanofi, GSK, AstraZeneca, and CSL Technavio’s market research analysts predict the global H1N1 vaccines market to grow at a CAGR of almost 12% between 2016 and 2020….
This market analysis includes a detailed segmentation of the global human vaccine market by type of human vaccine (preventable human vaccines and therapeutic human vaccines), by composition (mono vaccine and combination vaccines), by route of administration (oral, intramuscular, intranasal, and intradermal), and by geography (Americas, APAC, and Europe). The key vendors analyzed in this…
London, 11 December 2015: Technavio, the independent tech-focused global research firm, has published a report on the global hepatitis drugs market 2015-2019, which is predicted to grow at a CAGR of 16.6% during the forecast period of 2014-2019. The pipeline for hepatitis drugs is quite robust, with multiple new drugs across various stages of…
Orphan drugs: Key market research findings Shorter development timelines of orphan drugs Growing inclination towards biological drugs Technavio has added a new market research report on the global orphan drugs market, which is expected to grow at a CAGR of around 10% between 2015 and 2019. Much of this market’s growth is propelled by…
This market research report presents a detailed segmentation of the animal health market in North America by animal type (commercial and companion) and by products (pharmaceuticals, biologicals, and medicinal feed additives). The key vendors analyzed in this report are Bayer, Elanco, Merck Animal Health, Merial, and Zoetis. Technavio’s market research analysts estimate the animal…
This industry research report segments the global hemophilia B market by disease severity (mild, moderate, and severe), by disease management (on-demand therapy, prophylaxis, and inhibitors), and by geography (APAC, EMEA, and the Americas). This report also includes a section on the key trends, drivers, and leading vendors in this market, including Baxter, Grifols, Novo…
